6.86  1.22 (21.63%)		09-29 15:59
Open: 5.42 High: 7.525 Volume: 157,285		Pre. Close: 5.64 Low: 5.2441 Market Cap: 102(M)

Short term
Mid term
Targets	6-month :	10.78	1-year :	13.68
Resists	First :	9.23	Second :	11.72
Pivot price	9.57
Supports	First :	5.21	Second :	4.33
MAs	MA(5) :	7.87	MA(20) :	9.78
	MA(100) :	10.14	MA(250) :	10.05
MACD	MACD :	-0.8	Signal :	-0.3
%K %D	K(14,3) :	12.5	D(3) :	10.3
RSI	RSI(14): 23.8
52-week	High :	11.72	Low :	5.21

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ ANZU ] has closed above bottom band by 8.6%. Bollinger Bands are 2248.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	7.54 - 7.59	7.59 - 7.64
Low:	5.16 - 5.2	5.2 - 5.24
Close:	6.77 - 6.86	6.86 - 6.95

Anzu Special Acquisition Corp I does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of industrial applications. The company was incorporated in 2020 and is based in Tampa, Florida.

Sat, 20 Apr 2024
Anzu Special Acquisition Corp I (NASDAQ:ANZUW) Trading 13.3% Higher - Defense World

Mon, 22 Jan 2024
MCRA Provides Anzu Special Acquisition Corp I with Strategic Diligence Support Leading to Envoy Medical Merger ... - PR Newswire

Thu, 02 Nov 2023
GeoTech Wars - De-Risking Venture Capital with Anzu Partners co-founder David Michael - CSIS | Center for Strategic and International Studies

Wed, 04 Oct 2023
Another Minnesota med-tech firm goes public, trading on Nasdaq - Star Tribune

Wed, 04 Oct 2023
Hearing loss tech developer Envoy goes public in SPAC deal - Mass Device

Tue, 03 Oct 2023
Minnesota-Based Envoy Medical Goes Public Via SPAC - Twin Cities Business Magazine

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Financial Services
Industry: Shell Companies
Shares Out	4 (M)
Shares Float	3 (M)
Held by Insiders	0 (%)
Held by Institutions	97.6 (%)
Shares Short	2 (K)
Shares Short P.Month	1 (K)

EPS	0.05
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-1.39
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-1.4 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	-4 (M)
Levered Free Cash Flow	1 (M)

PE Ratio	114.33
PEG Ratio	0
Price to Book value	-4.94
Price to Sales	0
Price to Cash Flow	-6.82

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.